06/05/2026
, in partnership with ALS Network, is proud to announce continued investment in groundbreaking through a second year of funding for , a company developing innovative approaches to restore normal RNA processing and advance potential new treatments for ALS.
This investment reflects our commitment to accelerating research, fostering collaboration, and bringing hope to people and families affected by ALS.
Read more about this promising research and what it could mean for the future of ALS treatment: https://ow.ly/oF2Z50Z80jj